NCT03155074

Brief Summary

The HILT study is a prospective, single-blinded, randomized controlled trial comparing a high-intensity exercise training intervention with usual care among adult lung transplant recipients. Patients randomized to the training intervention arm will undergo individually tailored high-intensity exercise training (80-95% of maximum heart rate) three hours per week for 20 weeks. Training will be conducted at local fitness centers on a one-on-one basis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 10, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 16, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

August 22, 2017

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2019

Completed
Last Updated

November 28, 2023

Status Verified

November 1, 2023

Enrollment Period

1.4 years

First QC Date

May 10, 2017

Last Update Submit

November 27, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in peak oxygen uptake

    Measured by cardiopulmonary exercise test

    0-20 weeks

Secondary Outcomes (7)

  • Change in total body composition (fat, muscle and bone mass)

    0-20 weeks

  • Change in forced expiratory volume in one second (FEV1)

    0-20 weeks

  • Change submaximal exercise capacity

    0-20 weeks

  • Change in leg strength

    0-20 weeks

  • Change in upper body strength

    0-20 weeks

  • +2 more secondary outcomes

Study Arms (2)

High-Intensity Training

EXPERIMENTAL
Behavioral: High-intensity training

Usual Care

NO INTERVENTION

Interventions

The exercise program will include a cardiovascular warm-up, high intensity interval training and progressive resistance training (PRT). The intervention will focus on high-intensity training, mainly by uphill walking on a treadmill at 80-95 % of the maximal heart rate and PRT in three series at 6-12 RM by leg press, chest press, back extension, seat row, and front raises. During the first four weeks, the patients will be introduced to the program while focusing on safety, techniques and familiarization. The endurance intensity and strength load will then continuously increase based on the patients' improvement, tolerance of dyspnea, and feelings of well-being or fatigue on each exercise day.

High-Intensity Training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Stable medical condition in the opinion of the enrolling investigator
  • Able and willing to give informed consent

You may not qualify if:

  • Expected survival less than 12 months
  • Unable to complete a maximal exercise test on a treadmill until exhaustion
  • Language barrier that interferes with data collection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oslo University Hospital

Oslo, Norway

Location

Related Publications (1)

  • Gutierrez-Arias R, Martinez-Zapata MJ, Gaete-Mahn MC, Osorio D, Bustos L, Melo Tanner J, Hidalgo R, Seron P. Exercise training for adult lung transplant recipients. Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD012307. doi: 10.1002/14651858.CD012307.pub2.

MeSH Terms

Interventions

High-Intensity Interval Training

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Elisabeth Edvardsen, PhD

    Oslo University Hospital, Norwegian School of Sport Sciences

    PRINCIPAL INVESTIGATOR
  • Michael T Durheim, MD

    Oslo University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant

Study Record Dates

First Submitted

May 10, 2017

First Posted

May 16, 2017

Study Start

August 22, 2017

Primary Completion

January 31, 2019

Study Completion

January 31, 2019

Last Updated

November 28, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations